Improvement of blood pressure control in hypertensive patients with renal diseases

Yuko Ohta1, Kazuhiko Tsuruya, Koji Fujii

  • 1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. yukoo@qmed.hosp.go.jp

Insights

Strict blood pressure control improved for hypertensive patients with renal disease after recent guidelines. Renal disease patients achieved lower blood pressure levels than those without renal disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Management

Background:

  • Recent hypertension guidelines emphasize strict blood pressure (BP) control for patients with renal diseases (RD).
  • Understanding current BP control status and changes post-guideline publication is crucial for optimizing patient care.

Purpose of the Study:

  • To assess the current BP control status in hypertensive patients with and without RD.
  • To evaluate changes in BP control before and after the publication of major hypertension guidelines.

Main Methods:

  • A retrospective analysis of 489 hypertensive patients (with/without RD) visiting a specialized outpatient clinic.
  • Comparison of BP levels and control rates between 1996 and 2003, analyzing prescription patterns of medications like angiotensin II receptor blockers (ARBs).

Main Results:

  • In 2003, BP levels in RD patients were 134/78 mmHg, significantly lower than in 1996 (141/85 mmHg, p<0.05).
  • The frequency of strict BP control (<130/80 mmHg) in RD patients increased from 11.8% in 1996 to 28.9% in 2003 (p<0.01).
  • ARBs were more frequently prescribed to RD patients and their use increased significantly from 1996 to 2003.

Conclusions:

  • Hypertensive patients with RD visiting the clinic showed improved BP control in recent years.
  • BP levels in RD patients were lower than in non-RD patients, potentially reflecting increased physician awareness of strict BP control importance in RD.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...